With reference to the discrepancy email dated 16/03/2026 regarding submission of quarterly cash flow figures instead of half yearly figures, we would like to clarify that the cash flow ....
Awaiting price reaction for this filing.
Nutraplus India Ltd's Board, meeting on October 25, 2025, approved its unaudited standalone results for the quarter and half-year ended September 30, 2025. The statutory auditor, Raman S. Shah & Associates, issued a Qualified Limited Review Report, flagging that the company failed to meet SEBI listing timelines and did not provide required financial data on time. An Emphasis of Matter was also raised, noting the company lost all its property, plant and equipment under the SARFAESI Act, 2002 after being declared a Non-Performing Asset in FY 2019-20, with the bank's auction process delayed due to COVID-19. The half-year cash flow shows a negative operating cash flow of approximately Rs 35.85 lakhs, and the balance sheet reflects a negative total equity position, indicating severe financial distress.
This is a significant red flag for shareholders — the qualified audit opinion, lost PPE under SARFAESI, NPA status since FY19-20, and negative equity suggest the company is in deep financial trouble and faces serious going-concern risks. Investors should expect continued negative sentiment and high risk on this stock.